Clinical Trial Update: Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

View source ↗

Summary

An observational study is evaluating the effectiveness of direct oral anticoagulants for secondary thrombosis prevention in low-risk antiphospholipid syndrome p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antiphospholipid Syndrome
• Thrombophilia
• Venous Thrombosis

Drugs mentioned

• Eliquis (apixaban)
• Pradaxa (dabigatran etexilate)
• Savaysa (edoxaban)
• Xarelto (rivaroxaban)

Snippet

Sponsor: Infanta Leonor University Hospital | Conditions: Antiphospholipid Syndrome (APS), Venous Thrombosis (Disorder) | Status: RECRUITING